Circassia Pharmaceuticals (CIR)

Company name:Circassia Pharmaceuticals Plc
EPIC:CIRTrading Currency:GBX
Market Sector:ASM6ISIN:GB00BJVD3B28
Market Segment:AMSMShare Type:DE
WWW Address:Description:ORD 0.08P
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Offer Open High Low Volume
 22.60 images.advfn.com/imagesnew/2/gb/up 0.2 [0.89] 22.50 22.70 23.00 23.00 22.50 1,061,754
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 84.72 374.87 -0.28 -34.00 - - - 66.60 - 13.25

Circassia Pharmaceuticals Key Figures

(at previous day's close)
Market Cap.84.72m
Shares In Issue374.87m
Prev. Close22.40
PE Ratio- 
Dividend Yield-%
EPS - basic-34.00p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-10.83p
Return On Equity (ROE)-93.01%
Operating Margin-115.53%
PEG Factor- 
EPS Growth Rate-9.68%
Dividends PS Growth Rate-%
Net Debt140.80m
Gross Gearing59.04%
Quick Assets71.90m
Net Working Capital-48.30m
Intangibles / Fixed Assets99.74%
Turnover PS12.88p
Pre-Tax Profit PS-14.89p
Retained Profit PS-31.24p
Cash PS10.86p
Net Cash PS-22.33p
Net Tangible Asset Value PS *-27.96p
Net Asset Value PS33.58p
Spread0.20 (0.88%) 

Circassia Pharmaceuticals Balance Sheet

CIR:Liabilities+EQCIR:Assets

Share Price Performance

Sample Period HighLow
1 week24.5019.80
4 weeks24.5016.25
12 weeks24.5015.00
1 year66.6013.25

Share Price Chart (5 years)

Circassia Pharmaceuticals Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week20.602.009.7119.804.5822.05
4 weeks18.004.6025.5616.255.1419.80
12 weeks19.003.6018.9515.003.4918.30
26 weeks19.003.6018.9513.255.5618.30
1 year65.50-42.90-65.5013.253.3419.75
3 years89.50-66.90-74.7513.251.2024.39
5 years286.00-263.40-92.1013.250.8450.60

Circassia Pharmaceuticals Key Management Ratios

Circassia Pharmaceuticals Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 0.24 
Tobin's Q Ratio (excl. intangibles)0.63 
Dividend Yield-%
Market-to-Book Ratio0.67 
Price-to-Pre-Tax Profit PS-1.52 
Price-to-Retained Profit PS-0.72 
Price-to-Cash Flow PS-2.09 
Price-to-Sales PS1.75 
Price-to-Net Tangible Asset Value PS-0.81 
Price-to-Cash PS2.08 
Net Working Capital PS-12.88 
Price Pct to Working Capital PS-1.75%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

Circassia Pharmaceuticals Financial Ratios

(Leverage Ratios)
Debt Ratio31.20%
Debt-to-Equity Ratio0.45 
Debt-to-Equity Ratio (excl. Intgbl)-0.54 
Debt-to-Equity Market Value0.67 
Net Gearing45.80%
Net Gearing (excl. Intangibles)183.57%
Gross Gearing59.04%
Gross Gearing (excl. Intangibles)236.64%
Gearing Under 1 Year40.47%
Gearing Under 1 Year (excl. Intgbl)162.19%
Assets/Equity2.44 
Cash/Equity32.33 
(Liquidity Ratios)
Net Working Capital to Total Assets-15.71%
Current Ratio0.61 
Quick Ratio (Acid Test)0.58 
Liquidity Ratio0.33 
Cash & Equiv/Current Assets53.48%
(Solvency Ratios)
Enterprise Value101.12m
CFO/Sales-0.84 
CFO/Attributable Profit- 
CFO/Assets-0.13 
CFO/Debt-0.22 
Total Debt/Equity Market Value2.14 
Total Debt/Sales3.76 
Total Debt/Pre-Tax Profit-3.25 
Total Debt181.50m
Total Debt/Net Current Assets-3.76%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-10.86%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs2 
Beta (60-Mnth)Beta (36-Mnth)
-0.28190.0558

Circassia Pharmaceuticals Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-30.49%
Return On Assets (ROA)-33.00%
Net Profit Margin-242.44%
Assets Turnover0.14 
Return On Equity (ROE)-93.01%
Return On Investment (ROI)-42.23%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-242.44%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.28 
Fixed Assets Turnover0.19 
Current Assets Turnover0.51 
Net Working Capital Turnover 
Inventory Turnover10.50 
(Other Operating Ratios)
Total Assets-to-Sales7.35 
Debtors-to-Sales97.93%
Debt Collection Period357.44Days

Circassia Pharmaceuticals Dividends

Announcement DateTypeCurr.Dividend AmountPeriod StartPeriod EndEx DateRecord DatePayment DateTotal Dividend Amount
-FinalGBP-31/12/200431/12/2005----
-FinalGBP-31/12/200331/12/2004----
-FinalGBP-31/12/200231/12/2003----

Circassia Pharmaceuticals Fundamentals

 31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)
turnover10.80100.00%23.10100.00%46.30100.00%48.30100.00%m
pre tax profit-62.80-581.48%-144.90-627.27%-113.60-245.36%-55.80-115.53%m
attributable profit-49.90-462.04%-137.30-594.37%-99.10-214.04%-117.10-242.44%m
retained profit-49.90-462.04%-137.30-594.37%-99.10-214.04%-117.10-242.44%m
eps - basic (p)-20.00 -48.00 -31.00 -34.00 
eps - diluted (p)-20.00 -48.00 -31.00 -34.00 
dividends per share- - - - 

Circassia Pharmaceuticals Balance Sheet

 31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)
CIR:Liabilities+EQCIR:AssetsCIR:Liabilities+EQCIR:AssetsCIR:Liabilities+EQCIR:AssetsCIR:Liabilities+EQCIR:Assets
 31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)
ASSETS
fixed assets fixed assets1.300.27%1.400.42%1.400.35%0.500.16%m
intangibles intangibles246.8050.45%176.8052.92%209.7052.11%230.7075.05%m
fixed investments fixed investments0.200.04%0.900.27%78.4019.48%0.100.03%m
current assets - other current assets - other--%--%--%--%m
stocks stocks3.000.61%4.601.38%5.001.24%4.201.37%m
debtors debtors71.9014.70%53.0015.86%63.4015.76%31.2010.15%m
cash & securities cash & securities166.0033.93%97.4029.15%44.5011.06%40.7013.24%m
TOTAL489.20100%334.10100%402.40100%307.40100%m
LIABILITIES
creditors - short creditors - short48.309.87%21.506.44%30.807.65%124.4040.47%m
creditors - long creditors - long31.206.38%31.909.55%146.8036.48%57.1018.58%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL79.5016.25%53.4015.98%177.6044.14%181.5059.04%m
EQUITY
ord cap, reserves ord cap, reserves408.5083.50%280.7084.02%224.8055.86%125.9040.96%m
prefs, minorities prefs, minorities1.200.25%--%--%--%m
TOTAL409.7083.75%280.7084.02%224.8055.86%125.9040.96%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Circassia Pharmaceuticals Cash Flow Statement

31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)
Operating CF-55.80-56.70-57.60-40.60m
Pre-Financing CF-122.90-69.10-52.40-25.00m
Retained CF135.70-72.70-54.00-4.70m

Circassia Pharmaceuticals Brokers

Broker infomation is not available for this class of stock.
Your Recent History
LSE
CIR
Circassia ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20191210 10:02:29